JOURNAL/ ARTICLES
JOURNAL
Systemic Lupus Erythematosus (Medical
Progress, May 2002)
John Darmawan, MD, PhD, FACR
Download
Reduced Burden of Disease and Improved Outcome of
Patients with Rheumatoid Factor Positive Rheumatoid
Arthritis Compared with Dropouts. A 10 Year
Observational Study (The Journal of Rheumatology, Aug
2003)
JOHN DARMAWAN, JOHANNES J. RASKER, and HENDRI
NURALIM
Download
ARTICLES
WHO-ILAR COPCORD Perspectives Past, Present,
and Future (The Journal of Rheumatology, Nov 2003)
JOHN DARMAWAN, MD. & KENNETH D. MUIRDEN, MD.
Download
A review of constitutional changes in APLAR (APLAR
Journal of Rheumatology 2003; 6: 114)
JOHN DARMAWAN, MD.
Download
Remission of Rheumatoid Arthritis with Millennium
Therapy (Kompas, Sunday, 19 May 2002)
Download
Lupus, Disease of A Hundred Faces (Kompas, Sunday, 21
July 2002)
Download
Email This Page
Print
This Page
|
|
| |
NEWS & EVENTS
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
16.11.2005
MabThera – a unique approach providing lasting
benefits for patients with rheumatoid arthritis
Comprehensive long-term clinical success achieved in
difficult-to-treat patients following just two
administrations, two weeks apart
›
more
|
|
 |
| |
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
06.09.2005
Roche files first rheumatoid arthritis indication for
MabThera in Europe
MabThera: a medicine used to treat non-Hodgkin's
lymphoma
MabThera delivers significant and sustained relief from
symptoms in patients with difficult-to-treat rheumatoid
arthritis.
›
more
|
|
|
|
| |
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum
06.04.2005
MabThera significantly improves symptoms in patients
with rheumatoid arthritis who inadequately responded to
anti-TNFα therapies
Third large randomised trial to evaluate efficacy and
safety of MabThera in RA
Roche, Genentech and Biogen Idec announced today that
REFLEX1, a pivotal Phase III study of MabThera (rituximab), successfully met its
primary endpoint in the group of patients with the most difficult-to-treat
rheumatoid arthritis (RA).
›
more
|
|
 |
Legal Disclamer
|
Legal Disclaimer
Copyright
©WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune
Diseases.
This Web site was developed in 2005 as a service provided by the
WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune
Diseases. This Web site provides selected information available
about lupus and arthritis. It is important that public see a
healthcare professional for detailed information about medical
conditions and treatment. This information is not intended to be a
substitute for the advice of a healthcare professional, or a
recommendation for any particular treatment plan. The WHO-ILAR
COPCORD Stage II Education on Treatment of the Autoimmune Diseases
has made and will continue to make efforts to include accurate and
up-to-date information on this Web site.
If you have any
questions, please contact us:
Webmaster
Phone: 62-24-8447-345
Fax: 62-24-8310-028
admin@LupusArthritisIndonesia.org
|
|
Bahasa 
